Literature DB >> 26545203

Probiotic Administration in Infants With Gastroschisis: A Pilot Randomized Placebo-Controlled Trial.

Weston T Powell1, Robyn A Borghese1, Karen M Kalanetra2, Majid Mirmiran1, David A Mills2, Mark A Underwood1.   

Abstract

OBJECTIVES: Infants with gastroschisis often require long periods of gastric suctioning and hospitalization. The impact of these interventions on the intestinal microbiota and attempts to alter the microbial community have not been studied. We sought to determine how the intestinal microbiota is influenced by the current treatment of gastroschisis and whether alteration of the intestinal microbiota with a probiotic microbe will influence length of hospitalization.
METHODS: We performed a randomized, placebo-controlled pilot study of administration of probiotic Bifidobacterium longum subsp. infantis in 24 infants with gastroschisis. The primary outcome was changes in the fecal microbiota, and the secondary outcome was length of hospital stay.
RESULTS: Administration of the probiotic or placebo was well tolerated, even during the period of gastric suctioning. The overall microbial communities were not significantly different between groups, although analysis of the final specimens by family demonstrated higher Bifidobacteriaceae, lower Clostridiaceae, and trends toward lower Enterobacteriaceae, Enterococcaceae, Staphylococcaceae, and Streptococcaceae in the probiotic group. Clinical outcomes, including length of hospital stay, did not differ between groups.
CONCLUSIONS: In this pilot study, there was significant in infants with gastroschisis that was partially attenuated by the administration of B longum subsp. infantis.

Entities:  

Mesh:

Year:  2016        PMID: 26545203      PMCID: PMC4854817          DOI: 10.1097/MPG.0000000000001031

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  22 in total

1.  A comparison of two probiotic strains of bifidobacteria in premature infants.

Authors:  Mark A Underwood; Karen M Kalanetra; Nicholas A Bokulich; Zachery T Lewis; Majid Mirmiran; Daniel J Tancredi; David A Mills
Journal:  J Pediatr       Date:  2013-08-29       Impact factor: 4.406

2.  Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB.

Authors:  T Z DeSantis; P Hugenholtz; N Larsen; M Rojas; E L Brodie; K Keller; T Huber; D Dalevi; P Hu; G L Andersen
Journal:  Appl Environ Microbiol       Date:  2006-07       Impact factor: 4.792

Review 3.  Development of gastroschisis: review of hypotheses, a novel hypothesis, and implications for research.

Authors:  Marcia L Feldkamp; John C Carey; Thomas W Sadler
Journal:  Am J Med Genet A       Date:  2007-04-01       Impact factor: 2.802

Review 4.  Potential role of the intestinal microbiota in programming health and disease.

Authors:  Olivier Goulet
Journal:  Nutr Rev       Date:  2015-08       Impact factor: 7.110

5.  Intestinal dysbiosis: novel mechanisms by which gut microbes trigger and prevent disease.

Authors:  Mark A Underwood
Journal:  Prev Med       Date:  2014-05-20       Impact factor: 4.018

Review 6.  The neonatal bowel microbiome in health and infection.

Authors:  Janet E Berrington; Christopher J Stewart; Stephen P Cummings; Nicholas D Embleton
Journal:  Curr Opin Infect Dis       Date:  2014-06       Impact factor: 4.915

Review 7.  Probiotics for prevention of necrotizing enterocolitis in preterm infants.

Authors:  Khalid AlFaleh; Jasim Anabrees
Journal:  Cochrane Database Syst Rev       Date:  2014-04-10

8.  Stool microbiota and vaccine responses of infants.

Authors:  M Nazmul Huda; Zachery Lewis; Karen M Kalanetra; Mamunur Rashid; Shaikh M Ahmad; Rubhana Raqib; Firdausi Qadri; Mark A Underwood; David A Mills; Charles B Stephensen
Journal:  Pediatrics       Date:  2014-07-07       Impact factor: 7.124

9.  The long term physical consequences of gastroschisis.

Authors:  Emma L Harris; Corrado Minutillo; Susannah Hart; Teresa M Warner; Madhur Ravikumara; Elizabeth A Nathan; Jan E Dickinson
Journal:  J Pediatr Surg       Date:  2014-10       Impact factor: 2.545

10.  Prevalence and correlates of gastroschisis in 15 states, 1995 to 2005.

Authors:  Russell S Kirby; Jennifer Marshall; Jean Paul Tanner; Jason L Salemi; Marcia L Feldkamp; Lisa Marengo; Robert E Meyer; Charlotte M Druschel; Russel Rickard; James E Kucik
Journal:  Obstet Gynecol       Date:  2013-08       Impact factor: 7.623

View more
  5 in total

Review 1.  Probiotic supplementation for neonates with congenital gastrointestinal surgical conditions: guidelines for future research.

Authors:  Shripada Rao; Meera Esvaran; Liwei Chen; Chooi Kok; Anthony D Keil; Ian Gollow; Karen Simmer; Bernd Wemheuer; Patricia Conway; Sanjay Patole
Journal:  Pediatr Res       Date:  2022-05-03       Impact factor: 3.756

2.  Probiotic supplementation in neonates with congenital gastrointestinal surgical conditions: a pilot randomised controlled trial.

Authors:  Shripada Rao; Meera Esvaran; Liwei Chen; Anthony D Keil; Ian Gollow; Karen Simmer; Bernd Wemheuer; Patricia Conway; Sanjay Patole
Journal:  Pediatr Res       Date:  2022-01-03       Impact factor: 3.953

3.  Impact of Clinical Factors on the Intestinal Microbiome in Infants With Gastroschisis.

Authors:  Allison J Wu; David J Lee; Fan Li; Nicole H Tobin; Grace M Aldrovandi; Stephen B Shew; Kara L Calkins
Journal:  JPEN J Parenter Enteral Nutr       Date:  2020-06-26       Impact factor: 3.896

Review 4.  Bifidobacterium longum Subspecies infantis (B. infantis) in Pediatric Nutrition: Current State of Knowledge.

Authors:  Maciej Chichlowski; Neil Shah; Jennifer L Wampler; Steven S Wu; Jon A Vanderhoof
Journal:  Nutrients       Date:  2020-05-28       Impact factor: 5.717

5.  Gut microbiota in neonates with congenital gastrointestinal surgical conditions: a prospective study.

Authors:  Shripada C Rao; Meera Esvaran; Sanjay K Patole; Karen N Simmer; Ian Gollow; Anthony Keil; Bernd Wemheuer; Liwei Chen; Patricia L Conway
Journal:  Pediatr Res       Date:  2020-03-16       Impact factor: 3.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.